Hi spinecho, While the market can do absolutely anything, I...

Hi spinecho,

While the market can do absolutely anything, I can't see much pullback from here (hence I bought more at $1.65 at open). Why?

They state they are expecting TGA approval this quarter. It'll take ages for individual doctors to order this test in volume... but whole country screening programs being converted to Colostat just makes sense.

For instance, if you look at the companies who were involved in study 7 you'll see a division of Sonic health (SHL!). As it happens, I understand that they also run the Bowel Screening program Australia-wide... so they already run the program, know its problems and are already be on top of the science and results here... now this is purely my guess but... would it be in their interest to use a better test that more people will utilise?? then... one little contract like that... will just be the start for RHY... let alone adding further cancers to their testing regime.

My summary... happy times for all holders!

Gav